The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women

Obesity Surgery

Volumn 16, Issue 10, 2006, Pages 1351-1358

  Arun, Janani ^a   Clements, Ronald H ^b   Lazenby, Audrey J ^c   Leeth, Ruth R ^b   Abrams, Gary A ^a,d  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bariatric surgery; Hepatic steatosis; Metabolic syndrome; Morbid obesity; Type 2 diabetes

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; STOMACH BYPASS;

ADULT; BODY MASS INDEX; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 33750553366     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206778663715     Document Type: Article

References (45)

1. Zelman S. The liver in obesity. Arch Intern Med 1952; 90: 141-56.
2. Abrams GA, Kunde SS, Lazenby AJ et al. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Hepatology 2004; 40: 475-83.
3. Brunt EM, Janney CG, Di Bisceglie AM et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
4. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Human Pathology 1989; 20: 594-8.
5. Clain DJ, Lefkowitch JH. Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 1987; 16: 239-52.
6. Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984; 8: 97-106.
7. Kern WH, Heger AH, Payne JH et al. Fatty metamorphosis of the liver in morbid obesity. Arch Pathol Lab Med 1973; 96: 342-6.
8. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
10. Lebovitz HE. The relationship of obesity to the metabolic syndrome. Int J Clin Pract 2003; 134 (Suppl): 18-27.
11. Grundy SM. What is the contribution of obesity to the metabolic syndrome? Endocrinol Metab Clin North Am 2004; 33: 267-82.
12. Angelico F, Del Ben M, Conti R et al. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003; 18: 588-94.
13. Marchesini G, Marzocchi R, Agostini F et al. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16: 421-7.
14. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003; 124: 71-9.
15. Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004; 8: 501-19.
16. Ludwig J, Viggiano TR, McGill DB et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
17. Powell EE, Cooksley WG, Hanson R et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
18. Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
19. Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056-62.
20. Angulo P, Keach JC, Batts KP et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
21. Bacon BR, Farahvash MJ, Janney CG et al. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
22. Teli MR, James OF, Burt AD et al. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-9.
23. Ong JP, Elariny H, Collantes R et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005; 15: 310-5.
24. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
25. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
26. Colman P, Thomas D, Zimmet P et al. New classification and criteria for diagnosis of diabetes mellitus. Med J Aust 1999; 170: 375-8.
27. Luyckx FH, Desaive C, Thiry A et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes 1998; 22: 222-6.
28. Krai JG, Schaffner F, Pierson RN Jr et al. Body fat topography as an independent predictor of fatty liver. Metabolism 1993; 42: 548-51.
29. Marceau P, Biron S, Hould FS et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-7.
30. Wolf AM, Busch B, Kuhlmann HW et al. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. Obes Surg 2005; 15: 228-37.
31. Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40: 1387-95.
32. Tong W, Lai H, Yang C et al. Age, gender and metabolic syndrome-related coronary heart disease in U.S. adults. Int J Cardiol 2005; 104: 288-91.
33. Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-8.
34. Lee WJ, Huang MT, Wang W et al. Effects of obesity surgery on the metabolic syndrome. Arch Surg 2004; 139: 1088-92.
35. Freedman DS, Jacobsen SJ, Barboriak JJ et al. Body fat distribution and male/female differences in lipids and lipoproteins. Circulation 1990; 81: 1498-506.
36. Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) 2004; 1: 1-24.
37. Couillard C, Bergeron N, Prud'homme D et al. Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999; 19: 2448-55.
38. Kuk JL, Nichaman MZ, Church TS et al. Liver fat is not a marker of metabolic risk in lean premenopausal women. Metabolism 2004; 53: 1066-71.
39. Lofgren R, Hoffstedt J, Ryden M et al. Major gender differences in the lipolytic capacity of abdominal subcutaneous fat cells in obesity observed before and after long-term weight reduction. J Clin Endocrinol Metab 2002; 87: 764-71.
40. Fried SK, Krai JG. Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients. Int J Obes 1987; 11: 129-40.
41. Tamura S, Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1139-42.
42. Seki S, Kitada T, Sakaguchi H. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res 2005; 33: 132-4.
43. Oliveira CPMS, Faintuch J, Rascovski A et al. Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) - preliminary findings. Obes Surg 2005; 15: 502-5.
44. Mavrelis PG, Ammon HV, Gleysteen JJ et al. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology 1983; 3: 226-31.
45. de Almeida IT, Cortez-Pinto H, Fidalgo G et al. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr 2002; 21: 219-23.